logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Patel, Sanjay
    Born in October 1980
    Individual (36 offsprings)
    Officer
    2026-02-09 ~ now
    OF - Director → CIF 0
  • 2
    Patel, Mitul Harshad
    Born in June 1981
    Individual (41 offsprings)
    Officer
    2026-02-09 ~ now
    OF - Director → CIF 0
  • 3
    White, Shadrene Natasha
    Born in October 1993
    Individual (1 offspring)
    Officer
    2023-04-25 ~ now
    OF - Director → CIF 0
    Miss Shadrene Natasha White
    Born in October 1993
    Individual (1 offspring)
    Person with significant control
    2023-04-25 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

NW PHARMA LIMITED

Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Intangible Assets
248,125 GBP2024-04-30
Property, Plant & Equipment
20,808 GBP2024-04-30
Fixed Assets
268,933 GBP2024-04-30
Total Inventories
36,816 GBP2024-04-30
Debtors
157,295 GBP2024-04-30
Cash at bank and in hand
269,033 GBP2024-04-30
Current Assets
463,144 GBP2024-04-30
Net Current Assets/Liabilities
-266,990 GBP2024-04-30
Total Assets Less Current Liabilities
1,943 GBP2024-04-30
Net Assets/Liabilities
1,943 GBP2024-04-30
Equity
Called up share capital
1 GBP2024-04-30
Retained earnings (accumulated losses)
1,942 GBP2024-04-30
Average Number of Employees
52023-03-25 ~ 2024-04-30
Intangible Assets - Gross Cost
Net goodwill
250,000 GBP2024-04-30
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
1,875 GBP2023-03-25 ~ 2024-04-30
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
1,875 GBP2024-04-30
Intangible Assets
Net goodwill
248,125 GBP2024-04-30
Trade Debtors/Trade Receivables
Current
30,796 GBP2024-04-30
Trade Creditors/Trade Payables
Current
60,518 GBP2024-04-30
Other Taxation & Social Security Payable
Current
6,227 GBP2024-04-30

  • NW PHARMA LIMITED
    Info
    Registered number 14826773
    44 Charles Street, Greenhithe DA9 9AQ
    PRIVATE LIMITED COMPANY incorporated on 2023-04-25 (2 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-22
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.